In two studies of atypical AD, including PCA and lpvPPA, an 18F–AV1451 tau PET scan showed closer association with the glucose hypometabolism and cognitive deficits than did amyloid deposition [14,15]. The gene discussed is MAPT; the disease is Cognitive impairment.